ArticleIntestinal research2014

Safety and Efficacy of Adalimumab for Patients With Moderate to Severe Crohn's Disease: The Taiwan Society of Inflammatory Bowel Disease (TSIBD) Study.

Chen-Wang Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.